Alpha 2.0
Login Register
» Articles » PMID: 29381811

Less Can Be More: A Finite Treatment Approach for HBeAg-negative Chronic Hepatitis B

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2018 Jan 31
PMID 29381811
Citations 10
Authors
Pietro Lampertico
Thomas Berg
Affiliations
Soon will be listed here.
Citing Articles

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention.

Huang S, Long H, Huang J Pathogens. 2025; 14(1).

PMID: 39860969 PMC: 11768139. DOI: 10.3390/pathogens14010008.

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.

Kim K, Iwamoto M, Kitagawa K, Park H, Hayashi S, Tsukuda S PLoS Comput Biol. 2025; 21(1):e1012615.

PMID: 39787253 PMC: 11753647. DOI: 10.1371/journal.pcbi.1012615.

Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers.

Kitagawa K, Kim K, Iwamoto M, Hayashi S, Park H, Nishiyama T PLoS Comput Biol. 2024; 20(3):e1011238.

PMID: 38466770 PMC: 10957078. DOI: 10.1371/journal.pcbi.1011238.

Real-world tertiary referral centre experience stopping nucleos(t)ide analogue therapy in patients with chronic hepatitis B.

Azhari H, Frolkis A, Shaheen A, Israelson H, Pinto J, Congly S Can Liver J. 2023; 5(4):453-465.

PMID: 38144400 PMC: 10735201. DOI: 10.3138/canlivj-2022-0002.

Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy.

Kumar K, Jindal A, Gupta E, Trehanpati N, Shasthry S, Maiwall R J Clin Exp Hepatol. 2023; 14(1):101272.

PMID: 38076362 PMC: 10709173. DOI: 10.1016/j.jceh.2023.08.008.